EXCHANGE INCOME CORP. WKN: A1C30Q ISIN: CA3012831077 Kürzel: EIF Forum: Aktien Thema: Hauptdiskussion
65,75
EUR
+1,82 % +1,18
18:10:41 Uhr,
L&S Exchange
Kommentare 74
Summer.76,
18.02.2021 7:29 Uhr
0
Exchange Income Corporation Draws Strength from Diversity to Deliver Strong Results in Pandemic-Stricken 2020
https://www.newswire.ca/news-releases/exchange-income-corporation-draws-strength-from-diversity-to-deliver-strong-results-in-pandemic-stricken-2020-886150089.html
Net Debt Reduced Again in Fourth Quarter
...reported its financial results for the three- and twelve-months ending December 31, 2020. All amounts are in Canadian currency.
2020 Financial Highlights
• Generated Revenue of $1.15 billion
• Preserved EBITDA margins, with Consolidated EBITDA of $285 million
• Safeguarded Free Cash Flow less Maintenance Capital Expenditures, producing $113 million or $3.23 per share
• Earned Adjusted Net Earnings per share of $1.35
• Annual Free Cash Flow less Maintenance Capital Expenditures Payout Ratio of 71%
Q4 Financial Highlights
• Generated Revenue of $302 million
• Preserved EBITDA margins, with Consolidated EBITDA of $82 million
• Safeguarded Free Cash Flow less Maintenance Capital Expenditures, producing $41 million or $1.17 per share, an increase of 7% over the comparative period
• Earned Adjusted Net Earnings per share of $0.53
• Three Month Free Cash Flow less Maintenance Capital Expenditures Payout Ratio improved to 49%
...
Summer.76,
16.11.2020 14:06 Uhr
0
Exchange Income Corporation - A 3Q20 Beat, Continued Outperformance
https://seekingalpha.com/article/4389248-exchange-income-corporation-3q20-beat-continued-outperformance
Summer.76,
14.11.2020 19:24 Uhr
0
Exchange Income Corporation Demonstrates Resilience with Robust Third Quarter Performance
https://www.newswire.ca/news-releases/exchange-income-corporation-demonstrates-resilience-with-robust-third-quarter-performance-877268283.html
Strengthens Balance Sheet, Reduces Net Debt, Lowers Payout Ratio
• Revenue decreased 16% to $297.3 million
• Consolidated EBITDA decreased $5.8 million or 6% from 2019's record levels to $83.2 million
• Adjusted Net Earnings per share down 43% to $0.59
• Free Cash Flow less Maintenance Capital Expenditures improved 20% over the prior year to $44.4 million
• Free Cash Flow less Maintenance Capital Expenditures quarterly payout ratio strengthened to 45% compared to 49% in third quarter of 2019
• Free Cash Flow less Maintenance Capital Expenditures trailing twelve month payout ratio remains strong at 73%, improving over the 76% at June 30, 2020
...
Summer.76,
06.11.2020 9:59 Uhr
0
.
TraderFloTop,
18.01.2020 21:29 Uhr
0
So wie ich das sehe nur in Frankfurt. Evtll. Noch außerbörslich?
Wie sieht ihr die diversifikation hier? Und die Chancen in der Zukunft? Kaufen und liegen lassen?
Olli2111,
17.10.2019 12:10 Uhr
0
Handelbar ist sie nur in Frankfurt wenn man sie in Deutschland handeln möchte oder ?
B
Blublub1,
10.05.2019 22:07 Uhr
0
Ja vor einigen Wochen mal mit einer kleinen Position eingestiegen
VolksDepot,
20.02.2019 7:38 Uhr
0
Guten Morgen.
Ist hier noch jemand investiert?
Meistdiskutiert
|
|
Thema | ||
|---|---|---|---|
| 1 | Novo Nordisk nach Split | +1,45 % | |
| 2 | Iris Energy | +11,51 % | |
| 3 | Critical Metals: Grönland - Tanbreez seltene Erden | +3,94 % | |
| 4 | DAX Hauptdiskussion | +2,06 % | |
| 5 | NEL ASA Hauptdiskussion | -10,54 % | |
| 6 | Diginex | -2,31 % | |
| 7 | Beyond Meat Hauptdiskussion | +4,88 % | |
| 8 | Investmentchancen | -0,04 % | |
| 9 | PAYPAL Hauptdiskussion | -1,36 % | |
| 10 | NVIDIA Hauptdiskussion | +4,27 % | Alle Diskussionen |
Aktien
|
|
Thema | ||
|---|---|---|---|
| 1 | Novo Nordisk nach Split | +1,45 % | |
| 2 | Iris Energy | +11,51 % | |
| 3 | Critical Metals: Grönland - Tanbreez seltene Erden | +3,50 % | |
| 4 | NEL ASA Hauptdiskussion | -10,54 % | |
| 5 | Diginex | -2,31 % | |
| 6 | Beyond Meat Hauptdiskussion | +4,88 % | |
| 7 | Investmentchancen | -0,04 % | |
| 8 | PAYPAL Hauptdiskussion | -1,67 % | |
| 9 | Nio für normale Kommunikation | -0,16 % | |
| 10 | NVIDIA Hauptdiskussion | +3,92 % | Alle Diskussionen |